Literature DB >> 33479602

Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds.

Phillip R Lazzara1, Terry W Moore1,2.   

Abstract

Understanding and minimizing oxidative metabolism of aromatic compounds is a key hurdle in lead optimization. Metabolic processes not only clear compounds from the body, but they can also transform parent compounds into reactive metabolites. One particularly useful strategy when addressing metabolically labile or oxidation-prone structures is scaffold-hopping. Replacement of an aromatic system with a more electron-deficient ring system can often increase robustness towards cytochrome P450-mediated oxidation while conserving the structural requirements of the pharmacophore. The most common example of this substitution strategy, replacement of a phenyl ring with a pyridyl substituent, is prevalent throughout the literature; however scaffold-hopping encompasses a much wider scope of heterocycle replacement. This review will showcase recent examples where different scaffold-hopping approaches were used to reduce metabolic clearance or block the formation of reactive metabolites. Additionally, we will highlight considerations that should be made to garner the most benefit from a scaffold-hopping strategy for lead optimization. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2019        PMID: 33479602      PMCID: PMC7451012          DOI: 10.1039/c9md00396g

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  62 in total

1.  Discovery of new leads against Mycobacterium tuberculosis using scaffold hopping and shape based similarity.

Authors:  Ravindra D Wavhale; Elvis A F Martis; Premlata K Ambre; Baojie Wan; Scott G Franzblau; Krishna R Iyer; Kavita Raikuvar; Katarzyna Macegoniuk; Łukasz Berlicki; Santosh R Nandan; Evans C Coutinho
Journal:  Bioorg Med Chem       Date:  2017-07-19       Impact factor: 3.641

Review 2.  Plasma clearance.

Authors:  P L Toutain; A Bousquet-Mélou
Journal:  J Vet Pharmacol Ther       Date:  2004-12       Impact factor: 1.786

Review 3.  An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

Authors:  Esther F A Brandon; Christiaan D Raap; Irma Meijerman; Jos H Beijnen; Jan H M Schellens
Journal:  Toxicol Appl Pharmacol       Date:  2003-06-15       Impact factor: 4.219

Review 4.  Metabolism of xenobiotics of human environments.

Authors:  Edward Croom
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 5.  Classification of scaffold-hopping approaches.

Authors:  Hongmao Sun; Gregory Tawa; Anders Wallqvist
Journal:  Drug Discov Today       Date:  2011-10-26       Impact factor: 7.851

6.  6alpha-hydroxylation of taurochenodeoxycholic acid and lithocholic acid by CYP3A4 in human liver microsomes.

Authors:  Z Araya; K Wikvall
Journal:  Biochim Biophys Acta       Date:  1999-04-19

7.  Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase.

Authors:  Rhonda A Torres; Kenneth R Korzekwa; Daniel R McMasters; Christine M Fandozzi; Jeffrey P Jones
Journal:  J Med Chem       Date:  2007-08-25       Impact factor: 7.446

Review 8.  Significance of aldehyde oxidase during drug development: Effects on drug metabolism, pharmacokinetics, toxicity, and efficacy.

Authors:  Seigo Sanoh; Yoshitaka Tayama; Kazumi Sugihara; Shigeyuki Kitamura; Shigeru Ohta
Journal:  Drug Metab Pharmacokinet       Date:  2014-11-20       Impact factor: 3.614

9.  Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig, and man.

Authors:  R J Chenery; A Ayrton; H G Oldham; P Standring; S J Norman; T Seddon; R Kirby
Journal:  Drug Metab Dispos       Date:  1987 May-Jun       Impact factor: 3.922

Review 10.  An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion.

Authors:  J Caldwell; I Gardner; N Swales
Journal:  Toxicol Pathol       Date:  1995 Mar-Apr       Impact factor: 1.902

View more
  5 in total

1.  Novel PF74-like small molecules targeting the HIV-1 capsid protein: Balance of potency and metabolic stability.

Authors:  Lei Wang; Mary C Casey; Sanjeev Kumar V Vernekar; Rajkumar Lalji Sahani; Karen A Kirby; Haijuan Du; Huanchun Zhang; Philip R Tedbury; Jiashu Xie; Stefan G Sarafianos; Zhengqiang Wang
Journal:  Acta Pharm Sin B       Date:  2020-07-31       Impact factor: 11.413

2.  A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16.

Authors:  Chao Zheng; Daniel Holden; Ming-Qiang Zheng; Richard Pracitto; Kyle C Wilcox; Marcel Lindemann; Zachary Felchner; Li Zhang; Jie Tong; Krista Fowles; Sjoerd J Finnema; Nabeel Nabulsi; Richard E Carson; Yiyun Huang; Zhengxin Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-11-11       Impact factor: 10.057

3.  Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities.

Authors:  Romeo Romagnoli; Paola Oliva; Filippo Prencipe; Stefano Manfredini; Federica Budassi; Andrea Brancale; Salvatore Ferla; Ernest Hamel; Diana Corallo; Sanja Aveic; Lorenzo Manfreda; Elena Mariotto; Roberta Bortolozzi; Giampietro Viola
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-21

4.  Densely Functionalized 2-Methylideneazetidines: Evaluation as Antibacterials.

Authors:  Giovanni Petrillo; Cinzia Tavani; Lara Bianchi; Alice Benzi; Maria Maddalena Cavalluzzi; Lara Salvagno; Laura Quintieri; Annalisa De Palma; Leonardo Caputo; Antonio Rosato; Giovanni Lentini
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

5.  A Computer-Driven Scaffold-Hopping Approach Generating New PTP1B Inhibitors from the Pyrrolo[1,2-a]quinoxaline Core.

Authors:  Javier García-Marín; Mercedes Griera; Ramón Alajarín; Manuel Rodríguez-Puyol; Diego Rodríguez-Puyol; Juan J Vaquero
Journal:  ChemMedChem       Date:  2021-07-19       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.